Inhibition of the TNF-pathway: use of infliximab and etanercept as remission-inducing agents in cases of therapy-resistant chronic inflammatory disorders.

Source:http://linkedlifedata.com/resource/pubmed/id/12428187

Swiss Med Wkly 2002 Jul 27 132 29-30 414-22

Download in:

View as

Triples

General Info

PMID
12428187